| Identification | Back Directory | [Name]
D-Alanine, D-arginyl-D-tyrosyl-D-threonyl-D-valyl-D-α-glutamyl-D-leucyl- | [CAS]
868844-53-5 | [Synonyms]
RYTVELA
d-(RYTVELA)
H-(D)-Arg-(D)-Tyr-(D)-Thr-(D)-Val-(D)-Glu-(D)-Leu-(D)-Ala-OH
D-Alanine, D-arginyl-D-tyrosyl-D-threonyl-D-valyl-D-α-glutamyl-D-leucyl- | [Molecular Formula]
C38H62N10O12 | [MOL File]
868844-53-5.mol | [Molecular Weight]
850.97 |
| Hazard Information | Back Directory | [Uses]
d-(RYTVELA) is a specific inhibitor of human thymocyte proliferation with an IC50 of 1 nM. d-(RYTVELA) inhibits IL-1–induced signaling pathways[1]. | [References]
[1] Tiffany Habelrih, et al. Pharmacodynamic characterization of rytvela, a novel allosteric anti-inflammatory therapeutic, to prevent preterm birth and improve fetal and neonatal outcomes. Am J Obstet Gynecol. 2023, 228, 4. DOI:10.1016/j.ajog.2022.10.007 |
|
|